Inactivation of the CDKN2A Tumor-Suppressor Gene by...

Clinical Cancer Research 2014 / 03 Vol. 20; Iss. 6

Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome

Alhejaily, A., Day, A. G., Feilotter, H. E., Baetz, T., LeBrun, D. P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-13-2175
Date:
March, 2014
File:
PDF, 1.06 MB
english, 2014
Conversion to is in progress
Conversion to is failed